Alvaro Barrera

Alvaro Barrera

Auto-generated profile, based on publicly available information

Alvaro Barrera

Department of Psychiatry, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2017 in Psychological Medicine
Verified
Journal Article
Open access
BSBryony Sheaves
Bryony Sheaves
DFDaniel Freeman
Daniel Freeman
LILouise Isham
Louise Isham
JMJosephine McInerney
Josephine McInerney
ANAlecia Nickless
Alecia Nickless
ABAlvaro Barrera
Alvaro Barrera
Background: When patients are admitted onto psychiatric wards, sleep problems are highly prevalent. We carried out the first trial testing a psychological sleep treatment at acute admission (Oxford Ward sLeep Solution, OWLS).Methods: This assessor-blind parallel-group pilot trial randomised patients to receive sleep treatment at acute crisis [STAC, plus standard care (SC)], or SC alone (1 : 1). STAC included cognitive–behavioural therapy (CBT) for insomnia, sleep monitoring and light/dark exposure for circadian entrainment, delivered over 2 weeks. Assessments took place at 0, 2, 4 and 12 weeks. Feasibility outcomes assessed recruitment, retention of participants and uptake of the therapy. Primary efficacy outcomes were the Insomnia Severity Index and Warwick–Edinburgh Mental Wellbeing Scale at week 2. Analyses were intention-to-treat, estimating treatment effect with 95% confidence intervals.Results: Between October 2015 and July 2016, 40 participants were recruited (from 43 assessed eligible). All participants offered STAC completed treatment (mean sessions received = 8.6, s.d. = 1.5). All participants completed the primary end point. Compared with SC, STAC led to large effect size (ES) reductions in insomnia at week 2 (adjusted mean difference −4.6, 95% CI −7.7 to −1.4, ES −0.9), a small improvement in psychological wellbeing (adjusted mean difference 3.7, 95% CI −2.8 to 10.1, ES 0.3) and patients were discharged 8.5 days earlier. One patient in the STAC group had an adverse event, unrelated to participation.Conclusions: In this challenging environment for research, the trial was feasible. Therapy uptake was high. STAC may be a highly effective treatment for sleep disturbance on wards with potential wider benefits on wellbeing and admission length.

21 December 2004 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
ABA. Barrera
A. Barrera
PMP. J. McKENNA
P. J. McKENNA
GBG. E. Berrios
G. E. Berrios
Background. It has been hypothesized that the schizophrenic symptom of formal thought disorder is linked to both executive and semantic dysfunction. Method. Intellectually preserved schizophrenic patients with (n=15) and without (n=16) formal thought disorder, plus matched normal controls (n=17) were administered four executive and four semantic tests. Tests of verbal fluency and comprehension of grammar were also given. Results. The patients with formal thought disorder were significantly impaired on all four executive tests compared to the patients without the symptom. They were only impaired compared to non-thought-disordered patients on 1 of 4 semantic tests, which probed semantic associations between concepts. Naming performance did not distinguish the two groups, nor did a previously used measure of semantic fluency controlling for phonological fluency. Conclusions. The results provide support for a dysexecutive hypothesis of formal thought disorder in schizophrenia, and, in line with other studies, suggest that there may be a restricted ‘higher-order’ semantic deficit which spares naming.

11 February 2020 in Evidence Based Mental Health
Verified
Journal Article
Open access
PDF file
ABAlvaro Barrera
Alvaro Barrera
CGCarol Gee
Carol Gee
AWAndrew Wood
Andrew Wood
OGOliver Gibson
Oliver Gibson
DBDaniel Bayley
Daniel Bayley
JGJohn Geddes
John Geddes
Background All patients admitted to an acute inpatient mental health unit must have nursing observations carried out at night either hourly or every 15 minutes, to ascertain that they are safe and breathing. However, while this practice ensures patient safety, it can also disturb patients’ sleep, which in turn can impact negatively on their recovery. Objective This article describes the process of introducing artificial intelligence (‘digitally assisted nursing observations’) in an acute mental health inpatient ward, to enable staff to carry out the hourly and the 15 minutes observations, minimising disruption of patients’ sleep while maintaining their safety. Findings The preliminary data obtained indicate that the digitally assisted nursing observations agreed with the observations without sensors when both were carried out in parallel and that over an estimated 755 patient nights, the new system has not been associated with any untoward incidents. Preliminary qualitative data suggest that the new technology improves patients’ and staff’s experience at night. Discussion This project suggests that the digitally assisted nursing observations could maintain patients’ safety while potentially improving patients’ and staff’s experience in an acute psychiatric ward. The limitations of this study, namely, its narrative character and the fact that patients were not randomised to the new technology, suggest taking the reported findings as qualitative and preliminary. Clinical implications These results suggest that the care provided at night in acute inpatient psychiatric units could be substantially improved with this technology. This warrants a more thorough and stringent evaluation.

27 July 2018 in Bio-Design and Manufacturing
Verified
Journal Article
Open access
PDF file
ESErfan Soliman
Erfan Soliman
SRSarujan Ranjan
Sarujan Ranjan
TXTianyou Xu
Tianyou Xu
CGCarol Gee
Carol Gee
AHAidan Harker
Aidan Harker
JGJohn Geddes
John Geddes
There are 12 billion injections given worldwide every year. For many injections, the intramuscular route is favoured over the subcutaneous route due to the increased vascularity of muscle tissue and the corresponding increase in the bioavailability of drugs when administered intramuscularly. This paper is a review of the variables that affect the success of intramuscular injections and the implications that these success rates have in psychiatry and general medicine. Studies have shown that the success rates of intended intramuscular injections vary between 32 and 52%, with the rest potentially resulting in inadvertent subcutaneous drug deposition. These rates are found to be even lower for certain at-risk populations, such as obese patients and those on antipsychotic medications. The variables associated with an increased risk of injection failure include female sex, obesity, site of injection, and subcutaneous fat depth. New guidelines and methods are needed in order to address this challenge and ensure that patients receive optimum care. Looking forward, the best way to improve the delivery of intramuscular injections worldwide is to develop uniform algorithms or innovative medical devices to confirm or guarantee successful delivery at the bedside.

4 April 2018 in Behavioural and Cognitive Psychotherapy
Verified
Journal Article
Open access
PDF file
BSBryony Sheaves
Bryony Sheaves
LILouise Isham
Louise Isham
JBJonathan Bradley
Jonathan Bradley
CEColin Espie
Colin Espie
ABAlvaro Barrera
Alvaro Barrera
DFDaniel Freeman
Daniel Freeman
Background: Almost all patients admitted at acute crisis to a psychiatric ward experience clinically significant symptoms of insomnia. Ward environments pose challenges to both sleep and the delivery of therapy. Despite this, there is no description of how to adapt cognitive behavioural therapy (CBT) for insomnia to overcome these challenges. Aims: (i) To describe the key insomnia presentations observed in the Oxford Ward Sleep Solution (OWLS) trial and (ii) outline key adaptations aimed to increase accessibility and hence effectiveness of CBT for insomnia for a ward setting. Methods: Trial therapists collaboratively agreed the key insomnia presentations and therapy adaptations based on their individual reflective logs used during the trial. Results: Three key insomnia presentations are outlined. These are used to illustrate the application of 10 CBT for insomnia therapy adaptations. These include use of sleep monitoring watches to engage patients in treatment, stabilizing circadian rhythms, reducing the impact of night-time observations and managing discharge as a sleep challenge. Conclusions: Whilst inpatient wards bring challenges for sleep and therapy delivery, creative adaptations can increase the accessibility of evidence based CBT for insomnia techniques. This therapy has proven popular with patients.

1 January 2017 in Psychiatric Services
Verified
Journal Article
Closed access
MNMatthew M. Nour
Matthew M. Nour
MNMurraih H. Nour
Murraih H. Nour
OTOlga-Maria Tsatalou
Olga-Maria Tsatalou
ABAlvaro Barrera
Alvaro Barrera